All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

@daniellenstanton's testosterone therapy claims, fact-checked

danielle stanton

TikTok creator

23.1K viewsWatch on TikTok→

Quick answer

The creator describes a six-month course of testosterone injections for perimenopausal symptoms, reporting subjective improvements in energy at approximately three weeks and libido plus psychological wellbeing by month two. Testosterone therapy for perimenopausal women is supported by evidence primarily for hypoactive sexual desire disorder, with the 2019 Global Consensus Position Statement endorsing it for this indication while noting it remains largely off-label in the US. Energy and mood outcomes are less consistently demonstrated in RCT data and require careful interpretation in the absence of concurrent bloodwork reporting.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.

What did @daniellenstanton actually say?

The creator described feeling "energy increase" within about three weeks of starting testosterone injections, then noticing libido improvements and what she called "the feeling of the femininity coming back" by month two. By month six, she says it's "a great feeling" and urges other women to be patient, framing weeks-to-months as a realistic timeline. Her core message is anecdotal but emotionally specific: she is not selling a product here, just reporting her personal experience and encouraging other women to stick with treatment.

That framing matters. She is not claiming testosterone cures anything or quoting bloodwork. She is describing subjective experience over time, which is actually the honest way to talk about hormone therapy. Still, some of her framing deserves scrutiny.

Does the science back this up?

Partially, yes. The timeline she describes is biologically plausible, though it is on the faster end of what clinical data shows for most women.

Testosterone's pharmacokinetics depend heavily on the delivery method. With injections, serum levels rise within days, but symptomatic response typically lags behind serum levels by weeks to months. A 2019 systematic review by Davis et al. in The Lancet Diabetes and Endocrinology found that testosterone therapy in women showed measurable improvements in sexual function, particularly low libido and arousal, often within 4 to 12 weeks of reaching therapeutic levels. Energy improvements are less consistently documented in controlled trials and are harder to separate from placebo effect, lifestyle changes, or concurrent estrogen therapy.

A 2021 randomized controlled trial by Islam et al. in JAMA Internal Medicine found significant improvements in sexual function scores in postmenopausal and perimenopausal women on testosterone, but energy and mood outcomes were more variable and did not always reach statistical significance compared to placebo at 12 weeks. Three weeks for energy is possible; it is not the norm in trial data.

What did they get wrong (or right)?

She got the general arc right. Most women on testosterone do not see full benefit in week one, and the two-to-six-month window she describes aligns reasonably with what endocrinologists and the 2019 Global Consensus Position Statement on testosterone therapy for women (Wierman et al.) describe as a realistic evaluation window.

What she likely overstates is the three-week energy claim. Energy is one of the least reliably testosterone-specific outcomes in women. It can reflect better sleep, reduced anxiety, placebo response, or simultaneous changes in estrogen or lifestyle. Presenting it as a clear testosterone effect at week three is probably too clean. She also does not mention that testosterone therapy in women is largely off-label in the US and requires careful monitoring of levels to avoid virilization. That omission is not dangerous, but it is incomplete.

Her phrase "the feeling of the femininity coming back" is interesting and not something clinical trials measure, but it tracks with patient-reported outcomes around confidence and sexual responsiveness that do appear in qualitative research.

What should you actually know?

If you are a perimenopausal woman curious about testosterone therapy, here is what the evidence actually supports:

  • Testosterone therapy has the strongest evidence base for hypoactive sexual desire disorder (HSDD) in women. The 2019 Global Consensus Position Statement, co-authored by the Endocrine Society and ISSWSH, endorses it for this indication.
  • Energy and mood effects are real for some women but are not consistently demonstrated in controlled trials. They may reflect systemic hormonal optimization rather than testosterone alone, especially when estrogen is also being managed.
  • Timeline varies. Three weeks is fast. Six months to see the full picture is more realistic for most people.
  • Injections are not FDA-approved for women in the US. Most women are prescribed testosterone gel or cream compounded to lower doses. Injections are used off-label and carry higher variability in blood levels.
  • Monitoring matters. Without regular bloodwork, it is easy to overdose testosterone in women, leading to acne, hair loss, or irreversible voice changes. Her video says nothing about this, which is a real gap.

Should you trust this video?

As personal testimony, it is reasonably honest. She is not selling anything, she acknowledges the need for patience, and her timeline is not wildly implausible. But personal testimony is not medical guidance. The three-week energy claim is probably faster than most women will experience, and the video skips entirely over monitoring, dosing, off-label status, and the difference between testosterone and a complete hormone optimization protocol. If her experience resonates with you, that is a reason to have a conversation with a clinician who can order labs, not a reason to start injections.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 7 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @daniellenstanton's testosterone therapy claims, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Video claim decision path

Turn the claim into a safer next question

Direct answer

@daniellenstanton's testosterone therapy claims, fact-checked should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

Use the health tools and supporting evidence to prepare questions for your clinician.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Claim verdict

The useful answer behind this video

Claim being checked

The creator describes a six-month course of testosterone injections for perimenopausal symptoms, reporting subjective improvements in energy at approximately three weeks and libido plus psychological wellbeing by month two.

FormBlends verdict

The creator describes a six-month course of testosterone injections for perimenopausal symptoms, reporting subjective improvements in energy at approximately three weeks and libido plus psychological wellbeing by month two. Testosterone therapy for perimenopausal women is supported by evidence primarily for hypoactive sexual desire disorder, with the 2019 Global Consensus Position Statement endorsing it for this indication while noting it remains largely off-label in the US. Energy and mood outcomes are less consistently demonstrated in RCT data and require careful interpretation in the absence of concurrent bloodwork reporting.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The creator describes a six-month course of testosterone injections for perimenopausal symptoms, reporting subjective improvements in energy at approximately three weeks and libido plus psychological wellbeing by month two. Testosterone therapy for perimenopausal women is supported by evidence primarily for hypoactive sexual desire disorder, with the 2019 Global Consensus Position Statement endorsing it for this indication while noting it remains largely off-label in the US. Energy and mood outcomes are less consistently demonstrated in RCT data and require careful interpretation in the absence of concurrent bloodwork reporting.
  • The strongest evidence for testosterone therapy in women is for hypoactive sexual desire disorder, as endorsed by the 2019 Global Consensus Position Statement co-signed by the Endocrine Society and ISSWSH.
  • Davis et al. (2019, The Lancet Diabetes and Endocrinology) found sexual function improvements within 4-12 weeks in women on testosterone, making the creator's month-two libido report plausible.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • The strongest evidence for testosterone therapy in women is for hypoactive sexual desire disorder, as endorsed by the 2019 Global Consensus Position Statement co-signed by the Endocrine Society and ISSWSH.
  • Davis et al. (2019, The Lancet Diabetes and Endocrinology) found sexual function improvements within 4-12 weeks in women on testosterone, making the creator's month-two libido report plausible.
  • Energy improvements are less consistently documented than sexual function benefits in RCTs; Islam et al. (2021, JAMA Internal Medicine) found variable mood and energy outcomes compared to placebo at 12 weeks.
  • Testosterone injections are not FDA-approved for women in the US. Most clinical protocols use compounded gels or creams at low doses, and injections carry higher risk of level fluctuation.
  • Without regular bloodwork, testosterone overdosing in women can cause irreversible side effects including voice changes, clitoral enlargement, and hair loss. The video mentions none of this.
  • A realistic evaluation window for testosterone therapy in women is 3-6 months, not 3 weeks, per clinical consensus, though some women do report earlier subjective changes.
  • Personal testimony from a non-clinician on TikTok is not a substitute for individualized lab-guided hormone assessment, regardless of how relatable or well-intentioned the account is.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

danielle stanton · TikTok creator

23.1K views on this video

Replying to @Randa B #testosteronetherapy #perimenopause #hrt #womenshealth #fypシ゚viral

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by danielle stanton, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.